Position history for Avoro Capital Advisors LLC's holdings in MoonLake Immunotherapeutics
Avoro Capital Advisors LLC previously held 0 shares of MLTX (MoonLake Immunotherapeutics), worth $0 as of 2025-Q4.
Final Value
$0
Final Shares
0
Total Value Change
-$129.6M
Total Shares Change
-2.6M
Other major holders of MLTX: FMR LLC, CITADEL ADVISORS LLC
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $13.21 |
0 |
| 2025-Q3 | Decreased | 2M | -51.8% | $14.3M | 0.2% | $6.24 | 0 |
| 2025-Q2 | Increased | 4.2M | +49.8% | $195.9M | 3.4% | $47.52 | 79 |
| 2025-Q1 | Unchanged | 2.8M | 0.0% | $108.2M | 1.7% | $39.86 | 0 |
| 2024-Q4 | Unchanged | 2.8M | 0.0% | $150M | 2.1% | $53.02 | 0 |
| 2024-Q3 | Increased | 2.8M | 0.0% | $139.7M | 2.0% | $49.40 | 53 |
| 2024-Q2 | Increased | 2.8M | +7.4% | $121.8M | 1.6% | $43.97 | 52 |
| 2024-Q1 | Unchanged | 2.6M | 0.0% | $129.6M | 1.5% | $50.23 | 0 |